- Investing Ideas
- Japanese Pharmaceuticals & Biotech Too Big To Fail
Japanese Pharmaceuticals & Biotech Too Big To Fail
Results
4
Large established companies which pay a dividend.
4 companies
Astellas Pharma
Market Cap: JP¥4.1t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,270.00
7D
-1.3%
1Y
62.5%
Shionogi
Market Cap: JP¥2.5t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥3,027.00
7D
-0.7%
1Y
28.3%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,385.50
7D
3.5%
1Y
7.1%
Ono Pharmaceutical
Market Cap: JP¥1.2t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,439.50
7D
-0.08%
1Y
56.9%